rs147553344
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001909.5(CTSD):c.1202A>G(p.Asn401Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,612,900 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001909.5 missense
Scores
Clinical Significance
Conservation
Publications
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 10Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTSD | ENST00000236671.7 | c.1202A>G | p.Asn401Ser | missense_variant | Exon 9 of 9 | 1 | NM_001909.5 | ENSP00000236671.2 | ||
| ENSG00000250644 | ENST00000636615.1 | c.1071+263A>G | intron_variant | Intron 8 of 9 | 5 | ENSP00000490014.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152128Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000204 AC: 51AN: 250512 AF XY: 0.000228 show subpopulations
GnomAD4 exome AF: 0.000110 AC: 160AN: 1460772Hom.: 1 Cov.: 33 AF XY: 0.000113 AC XY: 82AN XY: 726728 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000112 AC: 17AN: 152128Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74314 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.N401S variant (also known as c.1202A>G), located in coding exon 9 of the CTSD gene, results from an A to G substitution at nucleotide position 1202. The asparagine at codon 401 is replaced by serine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -
Neuronal ceroid lipofuscinosis Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at